Latest Market News

Arena REIT has declared a quarterly distribution of 4.8125 cents per security, aligning with its FY26 guidance, while offering a discounted Dividend Reinvestment Plan to investors.

Genmin Limited has completed a A$25.7 million capital raise, wiping out its debt and positioning itself to accelerate development of its flagship Baniaka iron ore project in Gabon.

Epsilon Healthcare has bolstered its working capital through a $2 million loan from its Managing Director and deferred director-related payments until 2027, signaling confidence amid liquidity management efforts.

Qube Holdings has sold its 202-hectare Beveridge property interest for $111 million, booking a substantial $100 million pre-tax profit in FY26. The move frees Qube from development costs while keeping future operational options open.

TasFoods Ltd has secured shareholder approval to sell its Pyengana Dairy business and to execute a selective buy-back of nearly 50 million shares, marking a pivotal moment in its strategic reshaping.

Carlton Investments Limited has announced an on-market buy-back of up to 115,000 ordinary shares, set to run throughout 2026. The move signals a strategic capital management effort without requiring shareholder approval.

360 Capital Group’s board unanimously recommends shareholders accept TT Investments’ on-market takeover offer at $0.31 per security, matching a prior bid. Meanwhile, the company suspends its minimum holding buy-back program indefinitely.

Aspire Mining has secured a $69.9 million lump-sum EPC contract with China Coal Technology and Engineering Group’s international arm, significantly de-risking its Ovoot Coking Coal Project and targeting first coal production by late 2027.

Verbrec Limited has announced over $20 million in new contracts spanning biogas engineering, cyber security, pipeline maintenance, mining technology, and water security, reinforcing its leadership in energy transition and sustainable mining sectors.

EPX Limited has secured Wattwatchers Pty Limited through a Deed of Company Arrangement, backed by a $2.14 million placement and a Share Purchase Plan to raise additional funds. This strategic move enhances EPX’s energy monitoring capabilities and recurring revenue streams.

Avecho Biotechnology is close to completing recruitment for the interim analysis cohort of its pivotal Phase III trial testing a CBD capsule for insomnia, with results expected in the first half of 2026.

TT Investments, led by Executive Chairman Tony Pitt, has announced an unconditional all-cash on-market takeover offer for 360 Capital Group at $0.31 per security, representing a 24% premium to recent trading prices. The offer aims to consolidate ownership and may lead to delisting from the ASX.